期刊文献+

自动化微生物仪检测超广谱β-内酰胺酶漏检原因分析

Analysis on cause of some omission happened in detecting extended spectrum β-lactamases positive strains by VITEK-AMS
下载PDF
导出
摘要 目的:探讨自动微生物鉴定仪检测超广谱β-内酰胺酶(ESBLs)漏检原因。方法:用VITEK-AMS专用药敏卡GNS-143进行ESBLs检测,对ESBLs阴性的菌株用纸片扩散法进行确证,并用头孢他啶、头孢噻肟、头孢曲松、氨曲南进行MIC的检测。结果:VITEK-AMS检测的168株ESBLs阴性的菌株用纸片扩散法确证为ESBLs阳性23株,占13.69%(23/168),其中CAZ抑菌圈直径增大值在5 mm的占43.48%(10/23)。ESBLs阳性株对头孢噻肟(CTX)、头孢曲松(CRX)、氨曲南(ATM)、头孢他啶(CAZ)的耐药率分别为69.56%(16/23),95.65%(22/23),86.95%(20/23)和13.04%(3/23)。结论:产酶量恰好落在3~4个稀释倍数之间,抑菌圈直径差在5 mm时,为仪器的"灰色区间"。以CAT和CTX为底物的自动微生物鉴定仪检测产ESBLs阴性时,需做纸片法补充试验,以免漏检。并根据国内细菌产酶特点,增加底物种类,以求取得更好的检测效果。 Objective:To investigate the cause of some omission happened in detecting extended spectrum β- lactamases ( ES- BLs) positive strains by using VITEK -AMS. Methods:VITEK- AMS GNS -143 was used to detect ESBLs, and testify the ESBLs negative strains with disc diffusion method, and agar dilution method for determining the minimum inhibitory concentrations (MIC) of Ceftazidime ( CAZ), Cefotaxime (CTX) , Ceftriaxone ( CRX), Aztreonam (ATM). Results: Among 168 strains were found to be ESBLs negative detected by using VITEK - AMS, 23 were found to be ESBLs positive detected by using disc diffusion method, positive rate was 13.69% (23/168). Which CAZ of antibacterial diameter increased value on 5mm were 43.48% ( 10/ 23). When strains producing ESBLs, their CAZ, CTX, CRX, ATM resistant rate were 69. 56%, 95.65%, 86.95% and 13.04% respectively. Conclusion:The "grey interval" of VITEK AMS is enzymes content of ESBLs producing lie just between 3 -4 dilution ratio, or the difference of antibacerical circle diameter for 5mm, disc diffusion method must be used as additional experiment for ESBLs negative strains, and must be using CAT and CTX as their substrates.
出处 《中国卫生检验杂志》 CAS 2009年第1期143-144,209,共3页 Chinese Journal of Health Laboratory Technology
关键词 自动微生物鉴定仪 超广谱Β-内酰胺酶 VITEK - A MS Extended spectrum β- lactamases
  • 相关文献

参考文献11

二级参考文献51

  • 1季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 2刘朝晖,王汉平,陈劲龙,杨银梅,叶惠芬,曾军.运用变性高效液相色谱对肺炎克雷伯菌产ESBL进行基因分型[J].中华微生物学和免疫学杂志,2005,25(9):764-767. 被引量:20
  • 3Yan J J, Wu SM, Tsai SH, et al. Prevalence of SHV 12 among clinical isolates of Klebsiella pneumoniae producing extended spectrum beta-lactamases and identification of a novel Amp C enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother,2000,44: 1438-1442.
  • 4Jacoby GA. Epidemiology of extended-spectrum beta-lactamases.Clin Infect Dis, 1998,27 : 81-83.
  • 5Li JB, Yu YS, Ma YL, et al. Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui. China Infection,2001,29:228-231.
  • 6Shannon K, Stepleton P, Xiang X, et al. Extended-spectrum betalactamases-producing Klebstella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol, 1998,36 : 3105-3110.
  • 7Gniadkowski M, Schneider I, Jungwirth R, et al. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals:identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother, 1998,42514-520.
  • 8Pai H, Lyu S, Lee JH, et al. Survey of extended-spectrum betalactamases in clinical isolates of Escherichla coli and Klebsiella pneumoniae: prevalence of TEM 52 in Korea. J Clin Microbol,1999,37 : 1758-1763.
  • 9许锦民,中华医学检验杂志,1998年,21卷,373页
  • 10Palucha A,Mikiewicz B,Gniadkowski M.Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase(ESBL)during a hospital outbreak:emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephlosporins[J].Antimicrob Agents Chemther,1999,43:393-396

共引文献384

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部